Pain relief in total knee replacement
Phase 1
- Conditions
- Health Condition 1: M171- Unilateral primary osteoarthritisof knee
- Registration Number
- CTRI/2020/07/026704
- Lead Sponsor
- Ruby Hall Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Belonging to ASA 1 and 2 undergoing unilateral arthropathy
Exclusion Criteria
a)Patients refusiong to give their consent for the study
b)Patients refusing Regional Anaesthesia/ or to have any continuous catheters in their body
c)Patients having absolute or relative contra- indications to Regional Anaesthesia
d)Patients having a revision TKR
e)History of neurological abnormality in the operating leg eg. History of chronic pain, stroke or previous nerve injury
f)Allergy or any contra- indication to drugs used in this study
g)Morbidly obese ( BMI > 40 )
h) History of alcohol or drug abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method assess analgesic efficacy by noting the VAS score at rest and on movement postoperativelyTimepoint: 0 hrs, 4 hrs, 8 hrs, 12 hrs, 24 hrs, 48 hrs
- Secondary Outcome Measures
Name Time Method 1) Ability to do straight leg raising test suggestive of motor or sensory block as a consequence of ACB or EA 2) Time to first successful ambulation 3) Time to first self micturition in ACB group <br/ ><br>(as EA group patients catheterized) 4) Analgesics used over 48 hours as a part of multimodal analgesic regimen in both groups 5) adverse events observed in either group 6) Length of hospital stay and 7) Chronic pain at 6 months follow up <br/ ><br>Timepoint: 0 hrs, 4 hrs, 8 hrs, 12 hrs, 24 hrs, 48 hrs